ROBBINS LARRY sold $20.6M of BFLY (indirect holdings)

ROBBINS LARRY sold 2,297,733 indirectly-held shares of Butterfly Network, Inc. (BFLY) at an average of $8.98 ($8.70–$9.54, $20.62M total) across 5 trades over 2026-08-13 to 2026-08-17.

Original reporting
SEC EDGAR · ROBBINS LARRY
Published Aug 17, 2026, 11:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 11:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BFLY
Neutral
medium confidence
Mentioned
$BFLY
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BFLYNeutralLow
01

Why it matters

Traders may reassess near-term sentiment around BFLY due to the transaction size ($20.62M) and the absence of a stated 10b5-1 plan, but there is no accompanying fundamental update in the text.

02

Market read

The only new information is the insider sale details (shares, price range, total value, and post-transaction holdings).

03

What to watch

The filing does not specify the reason for the sale, and it states no pre-arranged 10b5-1 plan, which can increase headline sensitivity without proving information content.

Relevance 7/10Novelty 4/10Timing: filed 2026-08-17, covering sales from 2026-08-13 to 2026-08-17

Background

This is an SEC Form 4 insider transaction for Butterfly Network, Inc. (BFLY) by director Larry Robbins, reported as an indirect holding sale.

Company-level read

Ticker impact

$BFLYNeutralMedium confidence
Context

Butterfly Network director Larry Robbins sold $20.62M of BFLY shares via an open-market sale across five trades at $8.6973 to $9.5418.

Expected impact

Near-term sentiment could soften, but follow-through is likely limited absent additional company-specific catalysts.

Evidence & confidence

Form 4 confirms transaction size and pricing range, yet the article provides no new operational, financial, or regulatory development for BFLY.

Market effects

No direct sector read-through beyond routine insider activity in medical imaging/diagnostics.

None indicated.

None indicated.

Counterpoint

A large indirect sale can reflect diversification or liquidity needs rather than negative expectations, especially when multiple trades are spread across days.

Key entities

  • Butterfly Network, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Larry Robbins

    Director who sold 2,297,733 shares indirectly in open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BFLYHigh

Butterfly Network Q3 Earnings Call Highlights

Butterfly Network (BFLY) reported Q3 record gross profit of $23.8M, up from a $3.8M loss last year. Adjusted EBITDA loss narrowed to $1.2M. Full-year 2026 revenue guidance raised to $123M-$126M. Company plans international strategy shift and expects FedRAMP authorization to boost government business. Cash reserves at $122M.

$BFLYMed

Butterfly (BFLY) Q3 2026 Earnings Call Transcript

Butterfly (BFLY) reported Q3 2026 revenue of $32.6M, beating guidance by 9%. The company raised full-year guidance and highlighted growth in U.S. enterprise contracts and international expansion. Key developments include FedRAMP authorization for federal government contracts and new partnerships in brain-computer interface and healthcare applications.

$BFLYMed

Butterfly Network, Inc. Q3 2026 Earnings Call Summary

Butterfly Network reported Q3 2026 earnings, highlighting revenue growth driven by its Embedded business and U.S. enterprise contracts. International performance lagged, but the company is shifting to an institutional model. Gross margins reached 73%, and full-year guidance was raised. The company plans to launch new chips and enter the cart-based ultrasound market by 2028. A $150M ATM program was established for financial flexibility.

$BFLYMed

Butterfly Network Reports Third Quarter 2026 Financial Results

Butterfly Network, Inc. (BFLY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Butterfly Network Reports Third Quarter 2026 Financial Results Beats High End of Quarterly Revenue and Adjusted EBITDA Guidance • Delivered quarterly Revenue of $32.6 million, driven in part by Embedded revenue • Recorded highest gross margin in Company history at 73

$QSIMed

2 Brain-Computer Interface Stocks to Watch While Neuralink Stays Private

Neuralink, a private brain-computer interface (BCI) company, successfully helped a patient with ALS communicate. Investors cannot buy Neuralink, but two public companies, Quantum-Si (QSI) and Butterfly Network (BFLY), are connected to the BCI field. QSI makes research tools and saw a 7x volume spike, while BFLY supplies ultrasound chips to BCI developers like Merge Labs and Bridge Neurotech.

$BFLYHigh

Why is Butterfly Network stock climbing today?

Butterfly Network (BFLY) stock rose 1.6% pre-market after Canaccord Genuity initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and AI capabilities. Analysts highlight new products and partnerships. The stock has seen positive analyst activity, with a consensus target of $11.40. Q3 earnings are due October 29.